<p><b>DHT levels and estrous cycle pattern:</b> a) <b>DHT levels measured at 16 weeks of age.</b> (Mean± SEM; pg/ml)<b>:</b> measured in the serum by ELISA, control group (n = 9) DHT group (n = 10) and DHT+ liraglutide group (n = 11). DHT levels were 1.3 fold higher in the DHT treated rats compared to control irrespective of liraglutide treatment (p<0.05). b) <b>Estrous cycle pattern in the three groups.</b> Vaginal cytology was done every day starting at 8 week of life till the end of the study. Data presented are from the last week of the study. The figure shows pattern of two representative rats in each group including control, DHT and DHT+ Liraglutide. P: proestrus; E: estrus; M: metestrus; and D: diestrus.</p
Background: Cyclooxygenase 2 is a key enzyme which converts arachidonic acid into prostaglandins. Cy...
Background: Polycystic ovarian syndrome (PCOS) is an endocrine and complex metabolic disorder, assoc...
WOS: 000358467100006PubMed ID: 25366063We aimed to evaluate: (1) endometrial and ovarian tissue inju...
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of reproductive ag...
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of reproductive ag...
<p>(Mean± SEM): a) oral glucose tolerance test done at 16 weeks (n = 9 control, n = 8 DHT+liraglutid...
Objective: To characterize and compare the effect of DHEA and insulin plus hCG on ovarian morphology...
<p>(Mean± SEM; g): a) Rats were weighed at 4 weeks and again from 9–13 weeks and at 16 week. “#” den...
Aims: Explore the effects of dodder total flavone on polycystic ovary syndrome (PCOS) rat models ind...
AIMS: In polycystic ovary syndrome (PCOS), metabolic and cardiovascular dysfunction is related to h...
BACKGROUND: One of the most common reasons for infertility is polycystic ovary syndrome (PCOS). PCOS...
Polycystic ovary syndrome (PCOS) is associated with increased risk of venous thromboembolism (VTE) a...
INTRODUCTION: Polycystic ovary syndrome (PCOS) is a common endocrine system disorder among women of...
Objective: To investigate the developmental window in which E2 exposure produces irreversible change...
Introduction & Objective: Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic diso...
Background: Cyclooxygenase 2 is a key enzyme which converts arachidonic acid into prostaglandins. Cy...
Background: Polycystic ovarian syndrome (PCOS) is an endocrine and complex metabolic disorder, assoc...
WOS: 000358467100006PubMed ID: 25366063We aimed to evaluate: (1) endometrial and ovarian tissue inju...
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of reproductive ag...
Polycystic ovarian syndrome (PCOS) is the most common endocrine disorder in women of reproductive ag...
<p>(Mean± SEM): a) oral glucose tolerance test done at 16 weeks (n = 9 control, n = 8 DHT+liraglutid...
Objective: To characterize and compare the effect of DHEA and insulin plus hCG on ovarian morphology...
<p>(Mean± SEM; g): a) Rats were weighed at 4 weeks and again from 9–13 weeks and at 16 week. “#” den...
Aims: Explore the effects of dodder total flavone on polycystic ovary syndrome (PCOS) rat models ind...
AIMS: In polycystic ovary syndrome (PCOS), metabolic and cardiovascular dysfunction is related to h...
BACKGROUND: One of the most common reasons for infertility is polycystic ovary syndrome (PCOS). PCOS...
Polycystic ovary syndrome (PCOS) is associated with increased risk of venous thromboembolism (VTE) a...
INTRODUCTION: Polycystic ovary syndrome (PCOS) is a common endocrine system disorder among women of...
Objective: To investigate the developmental window in which E2 exposure produces irreversible change...
Introduction & Objective: Polycystic ovary syndrome (PCOS) is a complex endocrine and metabolic diso...
Background: Cyclooxygenase 2 is a key enzyme which converts arachidonic acid into prostaglandins. Cy...
Background: Polycystic ovarian syndrome (PCOS) is an endocrine and complex metabolic disorder, assoc...
WOS: 000358467100006PubMed ID: 25366063We aimed to evaluate: (1) endometrial and ovarian tissue inju...